Logos Global Management LP 13D and 13G filings for Elevation Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 1:34 pm Sale | 2024-12-31 | 13G | Elevation Oncology, Inc. ELEV | Logos Global Management LP | 0 0.000% | -3,500,000 (Position Closed) | Filing |
| 2024-11-14 7:05 pm Sale | 2024-09-30 | 13G | Elevation Oncology, Inc. ELEV | Logos Global Management LP | 3,500,000 5.900% | -150,000 (-4.11%) | Filing |
| 2024-01-22 4:57 pm Purchase | 2024-01-10 | 13G | Elevation Oncology, Inc. ELEV | Logos Global Management LP | 3,650,000 8.600% | 3,650,000 (New Position) | Filing |